Children's National Medical Center



Children’s National Medical Center, located in Washington, DC, is a leader in the development of innovative new treatments for childhood illness and injury. Serving the nation’s children for more than 140 years, Children’s National is the premier provider of acute pediatric care in the Washington metropolitan area.

The components of Children’s National Medical Center include:

  • The main hospital, known as the Sheikh Zayed Campus for Advanced Children’s Medicine features 303 beds, 54 of which are level IIIC NICU bassinets; a Level I pediatric trauma center which serves three states; and a critical care transport program via ambulance, helicopter, and fixed-wing airplane;
  • Eight Regional Outpatient Centers that provide specialty care around the region, including an Ambulatory Surgery Center;
  • Children's National Specialists of Virginia, LLC, a private, physician office-based practice affiliated with Children’s National;
  • A primary care program that includes health centers within the District of Columbia and owned practices throughout the metropolitan area;
  • Children’s National Health Network, with 400 affiliated pediatricians;
  • Children’s Research Institute which is a leader in basic and clinical research programs;
  • Two large Emergency Departments, located at the main campus and on the United Medical Center campus; and
  • Other subsidiaries that focus on school health services, mobile health services, community partnerships, and safety campaigns.

Children’s National’s internationally recognized team of pediatric healthcare professionals log more than 360,000 visits annually for patients who come from throughout the region, nation, and world. As one of the largest employers in the region, Children’s National has more than 6,000 employees, including 1,500 nurses and 900 physicians.

As a non-profit pediatric care provider, Children’s National has a mission to serve all children in its service area regardless of ability to pay. Children’s National is the largest provider of pediatric care in the District of Columbia.

Each year, Children’s National provides almost $50 million in uncompensated care. Children’s National trains more than 200 residents and fellows annually.

Children's National serves as the regional referral center for pediatric emergency, trauma, cancer, cardiac and critical care as well as neonatology, orthopaedic surgery, neurology, and neurosurgery. The Telemedicine Program at Children’s National provides distance learning and more than 1,000 consultations annually to regional providers, as well as international countries.

With an internationally recognized team of pediatric healthcare and research professionals, Children’s has one of the top federally funded pediatric research centers in the country. Children’s National is home to the only Clinical and Translational Science Award led by a pediatric hospital. The Sheikh Zayed Institute for Pediatric Surgical Innovation is also housed at Children’s National. 

Children’s National is consistently ranked among the best pediatric hospitals in America by U.S.News & World Report and the Leapfrog Group. Children’s National is a Magnet® designated hospital.

Housing Information

Families traveling more than 50 miles to Children’s National Medical Center for participation in clinical trials may be eligible for free housing at Family House or Ronald McDonald House. For more information, contact the unit social worker. Other short-term housing information can be found by contacting concierge services 202-476-2220.

Contact information


Department of Neurology

111 Michigan Ave NW

Washington, DC 20010

Phone: 202-476-5115

Fax: 202-476-2368


Principal Investigator
Pediatric Neuro-oncologist
Dr. Lindsay B. Kilburn is an attending clinician in the Division of Oncology within the Center for Cancer and Blood Disorders at Children's National Medical Center. Dr. Kilburn received her medical degree from Eastern Virginia Medical School and went on to complete her pediatric residency at the Children’s Hospital of The King’s Daughters, a pediatric hematology oncology fellowship at Texas Children’s Hospital and a clinical pharmacology fellowship at the Baylor College of Medicine. Presently, Dr. Kilburn is the study chair of two Pediatric Brain Tumor Consortium (PBTC) studies: PBTC-021 and PBTC-030. She is also the chair of newly accepted concept proposal for study of a MEK-inhibitor with a MTOR- Inhibitor. Dr. Kilburn is an integral member of both the clinical and research teams at Children’s National.
Co-Principal Investigator
Pediatric Neuro-oncologist
Dr. Roger J. Packer is Senior Vice-President, Center for Neuroscience and Behavioral Medicine, and is Director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National, Washington, DC. Dr. Packer’s present academic titles include Professor of Neurology and Pediatrics at The George Washington University and Clinical Professor of Neurosurgery at the University of Virginia in Charlottesville, Virginia. Prior to coming to Children’s National, Dr. Packer was Director of the Brain Tumor Program and Professor of Neurology and Pediatrics at the Children’s Hospital of Philadelphia, University of Pennsylvania. Throughout his career, Dr. Packer has been heavily involved in clinical and applied basic science research. Throughout his career, Dr. Packer has been heavily involved in clinical and applied basic science research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurogenetic diseases, and multiple other topics in general child neurology. Much of his research has focused on the development and performance of clinical trials for adults and children with neurologic, neuro-oncologic, and neurogenetic disorders, and he has received peer-reviewed grant support for this research. Many of the clinical trials in Neurofibromatosis and brain tumors are translational, bringing advances from the bench to the bedside expeditiously. Presently, Dr. Packer is principal investigator at Children’s National for the Pediatric Brain Tumor Consortium (PBTC), formed under the auspices of the National Cancer Institute; Chairman of the PBTC Low-Grade Glioma Committee; Group Chair of the Neurofibromatosis Clinical Trials Consortium; is Chair of the Medulloblastoma Committee of the Children’s Oncology Group; and P.I. for the Institution as part of the NINDS-sponsored Neuro-NEXT Clinical Trials Consortium. He has worked closely with the NCI and NINDS, and has served on multiple committees setting the directions for neurologic clinical and basic science research for the future. He headed the efforts in pediatrics for the program review, held by the NCI and NINDS, for brain tumors. Much of Dr. Packer’s clinical research has been translational in nature. He has been part of studies evaluating the molecular genetics of childhood and adult neurologic diseases and has also coordinated the first gene therapy study for children with malignant brain tumors in the United States. The majority of the studies now being coordinated by Dr. Packer are studies evaluating innovative agents aimed at the molecular underpinnings of neurologic disease. He has published over 275 original articles and 250 reviews and chapters.

Cynthia Arevalo


Chad Stephans


Sumita Chatterjee


Deborah Lafond, PNP

Hospice Care
Neuro- Radiologist

Cherry Ho, MD


Faith Crozier, PNP


Elaine Kulm, PNP


Lauren Hancock, PNP


Julie Albert, PNP